Jennifer Saultz, D.O.

Jennifer Saultz, D.O., is an Assistant Professor of Medicine in the Division of Hematology/Medical Oncology at Oregon Health & Science University. Her research focuses on clinical transplantation for hematological malignancies, including leukemia and myeloid neoplasia, with specific interests in donor selection, post-transplant cyclophosphamide platforms, and novel cellular therapies. Her recent work includes phase 1/2 trials of AlloNK® cell therapy for relapsed/refractory non-Hodgkin lymphoma, ruxolitinib plus venetoclax in acute myeloid leukemia, and machine learning analyses of donor age in haploidentical transplantation. She has published in Blood Advances, Leukemia, and Transplantation and Cellular Therapy, contributing to risk models for older transplant recipients.